ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01337661
Recruitment Status : Completed
First Posted : April 19, 2011
Last Update Posted : August 28, 2012
Sponsor:
Information provided by (Responsible Party):
MedImmune LLC

Brief Summary:
The purpose of this study is to observe how the inflammatory pathways differ in subjects with chronic obstructive pulmonary disease (COPD) during an acute exacerbation of COPD (AECOPD).

Condition or disease
Chronic Obstructive Pulmonary Disease

Detailed Description:
This is an observational study in adult male and female subjects with COPD to collect blood, endobronchial tissues and BAL to investigate the inflammatory genes/pathways associated with AECOPD at the time of exacerbation (ie, active disease) and at 6 weeks later (ie, stable disease).

Study Type : Observational
Actual Enrollment : 26 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: An Exploratory Study of the Cellular Inflammatory Mechanisms Associated With Chronic Obstructive Pulmonary Disease Exacerbations
Study Start Date : April 2011
Actual Primary Completion Date : January 2012
Actual Study Completion Date : February 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD Lung Diseases

Group/Cohort
COPD subjects
Adult male and female subjects with COPD



Primary Outcome Measures :
  1. Identification of how inflammatory pathways differ in COPD subjects [ Time Frame: 6 weeks ]
    Identify how inflammatory pathways differ in subjects with COPD during an acute exacerbation relative to when the disease is stable.


Secondary Outcome Measures :
  1. Biomarker Sample Repository [ Time Frame: 6 weeks ]
    Establish a biomarker sample repository to support future target validation for the treatment of subjects with COPD.


Biospecimen Retention:   Samples Without DNA
Blood, Endobronchial tissues and Bronchoalveolar (BAL) samples


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects referred to the hospital clinic with AECOPD
Criteria

Inclusion Criteria:

  • Physician-diagnosed acute exacerbations of chronic obstructive pulmonary disease
  • Current or ex-smoker with a tobacco history of 15 or more pack years
  • Females of childbearing potential must use birth control for the duration of the study.

Exclusion Criteria:

  • Evidence or history of clinically significant disease
  • Subjects with asthma
  • Subjects taking anti-leukotriene medications

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01337661


Locations
Ireland
Research Site
Dublin, Ireland, 15
Sponsors and Collaborators
MedImmune LLC
Investigators
Study Director: Rene van der Merwe, MBChB, MFPM MedImmune Ltd
Principal Investigator: Prof. Connor Burke BCF Diagnostics

Additional Information:
Responsible Party: MedImmune LLC
ClinicalTrials.gov Identifier: NCT01337661     History of Changes
Other Study ID Numbers: CD-RI-INDP-1048
First Posted: April 19, 2011    Key Record Dates
Last Update Posted: August 28, 2012
Last Verified: August 2012

Keywords provided by MedImmune LLC:
Chronic Obstructive Pulmonary Disease
COPD
Acute Exacerbation of COPD
AECOPD

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Disease Progression
Respiratory Tract Diseases
Disease Attributes
Pathologic Processes